CN104256652A - Oral multi-vitamin nano liposome - Google Patents
Oral multi-vitamin nano liposome Download PDFInfo
- Publication number
- CN104256652A CN104256652A CN201410520174.0A CN201410520174A CN104256652A CN 104256652 A CN104256652 A CN 104256652A CN 201410520174 A CN201410520174 A CN 201410520174A CN 104256652 A CN104256652 A CN 104256652A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- cobastab
- nano liposome
- liposome
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002502 liposome Substances 0.000 title claims abstract description 46
- 239000011782 vitamin Substances 0.000 title claims abstract description 35
- 229940088594 vitamin Drugs 0.000 title claims abstract description 34
- 239000007788 liquid Substances 0.000 claims abstract description 22
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 20
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 20
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 16
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 13
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 13
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 13
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims abstract description 12
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960003495 thiamine Drugs 0.000 claims abstract description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 10
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000011718 vitamin C Substances 0.000 claims abstract description 10
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 10
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims abstract description 10
- 239000011709 vitamin E Substances 0.000 claims abstract description 10
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 10
- 229940046009 vitamin E Drugs 0.000 claims abstract description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 9
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019152 folic acid Nutrition 0.000 claims abstract description 9
- 239000011724 folic acid Substances 0.000 claims abstract description 9
- 229960000304 folic acid Drugs 0.000 claims abstract description 9
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019157 thiamine Nutrition 0.000 claims abstract description 9
- 239000011721 thiamine Substances 0.000 claims abstract description 9
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims abstract description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims abstract description 7
- 229960002477 riboflavin Drugs 0.000 claims abstract description 7
- 235000000639 cyanocobalamin Nutrition 0.000 claims abstract description 6
- 239000011666 cyanocobalamin Substances 0.000 claims abstract description 6
- 229960002104 cyanocobalamin Drugs 0.000 claims abstract description 6
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 6
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 6
- 235000008160 pyridoxine Nutrition 0.000 claims abstract description 6
- 239000011677 pyridoxine Substances 0.000 claims abstract description 6
- 235000019192 riboflavin Nutrition 0.000 claims abstract description 6
- 239000002151 riboflavin Substances 0.000 claims abstract description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 4
- 235000010445 lecithin Nutrition 0.000 claims abstract description 4
- 239000000787 lecithin Substances 0.000 claims abstract description 4
- 229940067606 lecithin Drugs 0.000 claims abstract description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 3
- 229930003448 Vitamin K Natural products 0.000 claims abstract description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 3
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 3
- 235000019168 vitamin K Nutrition 0.000 claims abstract description 3
- 239000011712 vitamin K Substances 0.000 claims abstract description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 claims abstract description 3
- 229940046010 vitamin k Drugs 0.000 claims abstract description 3
- 229930003231 vitamin Natural products 0.000 claims description 28
- 235000013343 vitamin Nutrition 0.000 claims description 28
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 28
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 16
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 16
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 10
- 235000019155 vitamin A Nutrition 0.000 claims description 10
- 239000011719 vitamin A Substances 0.000 claims description 10
- 229940045997 vitamin a Drugs 0.000 claims description 10
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 8
- 229960002685 biotin Drugs 0.000 claims description 8
- 235000020958 biotin Nutrition 0.000 claims description 8
- 239000011616 biotin Substances 0.000 claims description 8
- 229940055726 pantothenic acid Drugs 0.000 claims description 8
- 235000019161 pantothenic acid Nutrition 0.000 claims description 8
- 239000011713 pantothenic acid Substances 0.000 claims description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract description 4
- 210000000813 small intestine Anatomy 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 229940011671 vitamin b6 Drugs 0.000 abstract 2
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229930003537 Vitamin B3 Natural products 0.000 abstract 1
- 229930003761 Vitamin B9 Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 235000019169 all-trans-retinol Nutrition 0.000 abstract 1
- 239000011717 all-trans-retinol Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000020510 functional beverage Nutrition 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229960003471 retinol Drugs 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000019160 vitamin B3 Nutrition 0.000 abstract 1
- 239000011708 vitamin B3 Substances 0.000 abstract 1
- 235000021470 vitamin B5 (pantothenic acid) Nutrition 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000021467 vitamin B7(Biotin) Nutrition 0.000 abstract 1
- 235000019159 vitamin B9 Nutrition 0.000 abstract 1
- 239000011727 vitamin B9 Substances 0.000 abstract 1
- 235000005282 vitamin D3 Nutrition 0.000 abstract 1
- 239000011647 vitamin D3 Substances 0.000 abstract 1
- 229940021056 vitamin d3 Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000012528 membrane Substances 0.000 description 4
- 239000011772 phylloquinone Substances 0.000 description 4
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 235000021590 normal diet Nutrition 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229940083466 soybean lecithin Drugs 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to an oral multi-vitamin nano liposome, belonging to the technical field of nutrient supplements. In multi-vitamin nano liposome oral liquid, nano liposome prepared from lecithin, cholesterol and tween-80 is used as an embedding agent, and the liposome contains vitamin A1, vitamin D3, vitamin E, vitamin K, vitamin C, vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B3 (nicotinic acid), vitamin B5 (pantothenic acid), vitamin B6 (pyridoxine), vitamin B7 (biotin), vitamin B9 (folic acid) and vitamin B12 (cyanocobalamin). The oral multi-vitamin nano liposome can be directly absorbed and utilized by small intestines, so that the absorption rate and the bioavailability of the oral multi-vitamin nano liposome are improved; and the oral multi-vitamin nano liposome can be widely applied to the industries of health-care food, functional beverage, cosmetics, medicine and the like, and is suitable for large-scale production.
Description
Technical field
The invention provides a kind of oral B B-complex nano liposomes, belong to nutrient prime replenisher technical field.
Background technology
Vitamin maintains the required type organic matter of human life activity, is also the important active substances keeping health.Vitamin content is in vivo little, but plays an important role in growth in humans, metabolism, growth course, can cause dysbolism, and cause various diseases during shortage.When body can not meet its vital movement needs from external world's picked-up vitamin, metabolic function will be caused disorderly, cause various disease.
Because vitamin kind is a lot, distinct, in the majority with separate constituent of the vitamin preparation of therefore at present domestic production, Cernevit-12 is less, and formulation is main mainly with tablet or capsule, and liquid oral vitamin is then main mainly with B family vitamin.For fat-soluble A, D, E, K, because it is water-soluble poor, bioavilability is low.Find after deliberation, the absorptivity in the liposoluble vitamin in tablet or capsule is 20% ~ 25%, and bioavailability is 30%; The absorptivity of the liposoluble vitamin in emulsification B B-complex is 40% ~ 45%, and bioavailability is 55%.The biological value of visible tablet or capsule B B-complex is 6% ~ 7.5%; The biological value of general emulsification B B-complex is 22% ~ 25%.
Summary of the invention
For overcoming the shortcoming that prior art exists, goal of the invention of the present invention is to provide a kind of B B-complex nano liposomes oral liquid, and it directly can be absorbed by small intestine, improves its absorptivity and bioavilability.
For realizing described goal of the invention, the invention provides a kind of B B-complex nano liposomes oral liquid, it is characterized in that, with the nano liposomes prepared by lecithin, cholesterol and Tween 80 for embedding medium, containing vitamin A in its liposome
1, vitamin D
3, vitamin E, vitamin K, vitamin C, Cobastab
1(thiamine), Cobastab
2(riboflavin), Cobastab
3(nicotinic acid), Cobastab
5(pantothenic acid), Cobastab
6(pyridoxol), Cobastab
7(biotin), Cobastab
9(folic acid), Cobastab
12(cyanocobalamin).
Preferably, described B B-complex nano liposomes oral liquid, containing 0.01 ~ 2mg vitamin A in every 10mL nano liposomes oral liquid
1, 1 ~ 50 μ g vitamin D
3, 0.5 ~ 300mg vitamin E, 2 ~ 500 μ g vitamin Ks
1, 10 ~ 300mg vitamin C, 0.2 ~ 10mg Cobastab
1(thiamine), 0.2 ~ 10mg Cobastab
2(riboflavin), 5 ~ 50mg Cobastab
3(nicotinic acid), 1 ~ 50mg Cobastab
5(pantothenic acid), 0.5 ~ 10mg Cobastab
6(pyridoxol), 10 ~ 1000 μ g Cobastabs
7(biotin), 50 ~ 1000 μ g Cobastabs
9(folic acid), 0.1 ~ 20 μ g Cobastab
12(cyanocobalamin).
Compared with prior art, B B-complex nano liposomes oral liquid provided by the invention, with lecithin, cholesterol and Tween 80 for embedding medium, emulsion-dynamic high-pressure micro jetting technology (D HPM) is adopted to prepare B B-complex nano liposomes, acquisition appearance transparent, average grain diameter are about 50nm, the B B-complex nano liposomes that envelop rate is greater than 90%, and ensure that the stability of vitamin in preparation process.Lipidization vitamin directly can be absorbed by small intestine, improves its absorptivity and bioavilability, and this product can be widely used in the industries such as health food, drinks, cosmetics, medicine, is applicable to large-scale production.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in detail.
B B-complex nano liposomes oral liquid provided by the invention, containing 0.01 ~ 2mg vitamin A in every 10mL nano liposomes oral liquid
1, 1 ~ 50 μ g vitamin D
3, 0.5 ~ 300mg vitamin E, 2 ~ 500 μ g vitamin Ks
1, 10 ~ 300mg vitamin C, 0.2 ~ 10mg vitamin B1 (thiamine), 0.2 ~ 10mg Cobastab
2(riboflavin), 5 ~ 50mg Cobastab
3(nicotinic acid), 1 ~ 50mg Cobastab
5(pantothenic acid), 0.5 ~ 10mg Cobastab
6(pyridoxol), 10 ~ 1000 μ g Cobastabs
7(biotin), 50 ~ 1000 μ g Cobastabs
9(folic acid), 0.1 ~ 20 μ g Cobastab
12(cyanocobalamin).
Embodiment 1:
The concrete preparation method of the B B-complex nano liposomes oral liquid that the embodiment of the present invention 1 provides is as follows:
S01: take soybean lecithin 5g, cholesterol 1g, Tween 80 1g, add 30ml in absolute ethyl alcohol (or chloroform, methyl alcohol or carrene etc.), then put into eggplant-shape bottle, on water-bath evaporimeter (bath temperature 40 DEG C ± 1 DEG C), be stirred to and dissolve to obtain solution a;
S02: get 5ml olive oil and put into container, and add 50mg vitamin A wherein
1, 0.5mg vitamin D
3, 1g vitamin E, 5mg vitamin K
1, mix, obtain liposoluble vitamin solution b;
S03: above-mentioned liposoluble vitamin solution b is joined in the solution a of step (1), stirs and evenly mixs, obtain solution c
S04: by 10g vitamin C, 0.1g thiamine, 0.1g Cobastab
2, 1.2g niacinamide, 0.5g pantothenic acid, 0.1g Cobastab
6, 30mg biotin, 40mg folic acid, 0.3mg Cobastab
12be dissolved in 10mL distilled water, obtain water soluble vitamin solution d;
The water soluble vitamin solution d of step (4) joins in step (3) solution c by S05, stirs and obtains solution e;
S06: evaporation under reduced pressure removed solvent is carried out to solution e;
S07: use spy formula Ultrasound Instrument to make the abundant aquation of lipid membrane 80 minutes under ice-water bath condition, until become transparent to emulsion;
S08: use Microfluidizer under 100MPa pressure to emulsion breast even 2 times;
S09: add distilled water to 1000ml, stir, then filter packing, obtains B B-complex nano liposomes oral liquid, and described B B-complex nano liposomes appearance transparent, average grain diameter are about 50.2nm, and envelop rate is 91%.
Embodiment 2:
The concrete preparation method of the B B-complex nano liposomes oral liquid that the embodiment of the present invention 2 provides is as follows:
S01: take soybean lecithin 5g, cholesterol 1g, Tween 80 1g, add 30ml in absolute ethyl alcohol (or chloroform, methyl alcohol or carrene etc.), then put into eggplant-shape bottle, on water-bath evaporimeter (bath temperature 50 DEG C ± 1 DEG C), be stirred to and dissolve to obtain solution a;
S02: get 5ml olive oil and put into container, and add 1mg vitamin A wherein
1, 0.1mg vitamin D
3, 50mg vitamin E, 0.2mg vitamin K
1, mix, obtain liposoluble vitamin solution b;
S03: above-mentioned liposoluble vitamin solution b is joined in the solution a of step (1), stirs and evenly mixs, obtain solution c;
S04: by 10g vitamin C, 0.1g thiamine, 0.1g Cobastab
2, 1.2g niacinamide, 0.5g pantothenic acid, 1g Cobastab
6, 3g biotin, 4g folic acid, 30mg Cobastab
12be dissolved in 10mL distilled water, obtain water soluble vitamin solution d;
S05: the water soluble vitamin solution d of step (4) is joined in step (3) solution c, stirs and obtain solution e;
S06: evaporation under reduced pressure removed solvent is carried out to solution e;
S07: use spy formula Ultrasound Instrument to make the abundant aquation of lipid membrane 40 minutes under ice-water bath condition, until become transparent to emulsion;
S08: use Microfluidizer under 100MPa pressure to emulsion breast even 6 times;
S09: add distilled water to 1000ml, stir, then filter packing, obtains B B-complex nano liposomes oral liquid, and described B B-complex nano liposomes appearance transparent, average grain diameter are about 49.8nm, and envelop rate is 91.2%.
Embodiment 3:
The concrete preparation method of the B B-complex nano liposomes oral liquid that the embodiment of the present invention 3 provides is as follows:
S01: take soybean lecithin 5g, cholesterol 1g, Tween 80 1g, add 30ml in absolute ethyl alcohol (or chloroform, methyl alcohol or carrene etc.), then put into eggplant-shape bottle, on water-bath evaporimeter (bath temperature 55 DEG C ± 1 DEG C), be stirred to and dissolve to obtain solution a;
S02: get 5ml olive oil and put into container, and add 40mg vitamin A wherein
1, 1mg vitamin D
3, 2g vitamin E, 4mg vitamin K
1, mix, obtain liposoluble vitamin solution b;
S03: above-mentioned liposoluble vitamin solution b is joined in the solution a of step (1), stirs and evenly mixs, obtain solution c;
S04: by 30g vitamin C, 1g thiamine, 1g Cobastab
2, 5g niacinamide, 0.5g pantothenic acid, 0.1g Cobastab
6, 30mg biotin, 40mg folic acid, 0.3mg Cobastab
12be dissolved in 10mL distilled water, obtain water soluble vitamin solution d;
S05: the water soluble vitamin solution d of step (4) is joined in step (3) solution c, stirs and obtain solution e;
S06: evaporation under reduced pressure removed solvent is carried out to solution e;
S07: use spy formula Ultrasound Instrument to make the abundant aquation of lipid membrane 40 minutes under ice-water bath condition, until become transparent to emulsion;
S08: use Microfluidizer under 100MPa pressure to emulsion breast even 10 times;
S09: add distilled water to 1000ml, stir, then filter packing, obtains B B-complex nano liposomes oral liquid, and described B B-complex nano liposomes appearance transparent, average grain diameter are about 50nm, and envelop rate is 90.8%.
B B-complex nano liposomes nutrient solution oral liquid prepared by the method utilizing the embodiment of the present invention 1 to provide is tested:
One, materials and methods
1. test specimen
B B-complex nano liposomes nutrient solution is obtained by formula provided by the invention and method.
2. animal used as test, grouping and hello oxygen method
2-1 experimental animal:
Screech owl white rabbit 6,2-3kg, is provided by Peking University's experimental animal center.
2-2 tests grouping: experimental rabbit is after laboratory adapts to 5 days, be divided into 3 groups at random, that is: water group (control group A) is fed in normal diet+filling, B B-complex (control group B) is fed in normal diet+filling and B B-complex nano liposomes nutrient solution (experimental group C) is fed in normal diet+filling, and described B B-complex has the vitamin with the equal proportioning of liposome provided by the invention;
2-3 experimental technique:
A treated animal is normally fed, and B treated animal gives to fill with hello B B-complex oral liquid 5ml every day.C treated animal gives B B-complex nano liposomes nutrient solution oral liquid 5ml every day.5 days experimental periods.Feed after 5 days, get blood, separation of serum, measure vitamine concentration in animal blood.METHOD FOR CONTINUOUS DETERMINATION 5 times, is averaged.
3. test index and method
By pharmacopeia annex (VID), adopt ultraviolet-visible spectrophotometer method.
Two, experimental result
Vitamin A in serum between three treated animals
1content results sees the following form:
Experimental result shows, liposomal encapsulated vitamin A
1absorbability is apparently higher than non-encapsulated, and the two has compared significant difference.The absorbability of other vitamin same is also apparently higher than non-encapsulated.
The structure of liposome (Liposome) take bimolecular film as the closed vesica of interlayer cyst wall.Various lipid and lipid mixture all can be used for preparing liposome, and phosphatide is the most frequently used.The main component of phosphatide is phosphatid ylcholine, phosphatidyl-ethanolamine, phosphatidylserine, phosphatidyl glycerol, phosphatidic acid etc.Phosphatide is the main component of cell membrane, and therefore liposome is in similar in human body cell, human body cell is had to the compatibility of height.Phosphatide is amphipathic molecule, containing hydrophilic radical (phosphate group and nitrogenous base) in its structure, and hydrophobic grouping (two longer hydrocarbon chain).Under a certain certain concentration condition, polar group is towards both sides aqueous phase, and the hydrocarbon chain of non-polar group faces each other and associates into a stable bilayer structure.Utilize the design feature of liposome can load lipophilic ingredients in the middle of bilayer molecules, and at centre of sphere place sealing embedding hydrophilic composition.Forming the another kind of material of lipid is cholesterol, and comparatively hydrophily is strong for its hydrophobicity, and be embedded in the middle of bilayer that phosphatide formed, mainly play a part to change pure phospholipid layer character, it plays a part adjustment membrane structure " mobility " as " buffer ".
B B-complex nano liposomes oral liquid of the present invention, its average grain diameter is at about 50nm, and except lipid adventitia, its main component is vitamin A
1, vitamin D
3, vitamin E, vitamin K
1, vitamin C, vitamin B complex.Product clear, thermodynamic stability are good, system is compatible good, and have high absorptivity and bioavilability.
Below the effect describing component of the present invention, preparation method in detail in conjunction with the embodiments and reach, but embodiment is only, for demonstration, the present invention is described.Description is only for explaining claims.But protection scope of the present invention is not limited to description.Any those skilled in the art of being familiar with are in the technical scope that the present invention discloses, and the change that can expect easily or replacement, all should be encompassed within protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain of claims.
Claims (2)
1. a B B-complex nano liposomes oral liquid, is characterized in that, with the nano liposomes prepared by lecithin, cholesterol and Tween 80 for embedding medium, containing vitamin A in its liposome
1, vitamin D
3, vitamin E, vitamin K, vitamin C, Cobastab
1(thiamine), Cobastab
2(riboflavin), Cobastab
3(nicotinic acid), Cobastab
5(pantothenic acid), Cobastab
6(pyridoxol), Cobastab
7(biotin), Cobastab
9(folic acid), Cobastab
12(cyanocobalamin).
2. B B-complex nano liposomes oral liquid according to claim 1, is characterized in that, containing 0.01 ~ 2mg vitamin A in every 10mL nano liposomes oral liquid
1, 1 ~ 50 μ g vitamin D
3, 0.5 ~ 300mg vitamin E, 2 ~ 500 μ g vitamin Ks
1, 10 ~ 300mg vitamin C, 0.2 ~ 10mg vitamin B1 (thiamine), 0.2 ~ 10mg Cobastab
2(riboflavin), 5 ~ 50mg Cobastab
3(nicotinic acid), 1 ~ 50mg Cobastab
5(pantothenic acid), 0.5 ~ 10mg Cobastab
6(pyridoxol), 10 ~ 1000 μ g Cobastabs
7(biotin), 50 ~ 1000 μ g Cobastabs
9(folic acid), 0.1 ~ 20 μ g Cobastab
12(cyanocobalamin).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410520174.0A CN104256652A (en) | 2014-10-08 | 2014-10-08 | Oral multi-vitamin nano liposome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410520174.0A CN104256652A (en) | 2014-10-08 | 2014-10-08 | Oral multi-vitamin nano liposome |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104256652A true CN104256652A (en) | 2015-01-07 |
Family
ID=52148337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410520174.0A Pending CN104256652A (en) | 2014-10-08 | 2014-10-08 | Oral multi-vitamin nano liposome |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104256652A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016197889A1 (en) * | 2015-06-12 | 2016-12-15 | 上海泽生科技开发股份有限公司 | Use of composition of vitamin complex in preparing drug for stimulating gastrointestinal system motility |
CN106667793A (en) * | 2017-01-17 | 2017-05-17 | 上海应用技术大学 | D-panthenol microcapsules and preparation method thereof |
CN107348514A (en) * | 2017-06-29 | 2017-11-17 | 安徽康博特保健食品有限公司 | A kind of preparation method of low-sugar type iron Couteat of Folic Acid |
CN113768057A (en) * | 2021-08-04 | 2021-12-10 | 深圳市红瑞生物科技股份有限公司 | Hair removing cream for cats |
US11351171B2 (en) | 2016-11-23 | 2022-06-07 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Composite vitamin composition promoting gastrointestinal system motility |
CN114796119A (en) * | 2022-02-21 | 2022-07-29 | 重庆医科大学 | Composite antioxidant co-carried liposome and preparation method thereof |
US11464797B2 (en) | 2017-03-07 | 2022-10-11 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Use of vitamin composition in preparing drug for preventing, treating, or delaying Alzheimer's disease |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101491499A (en) * | 2009-02-19 | 2009-07-29 | 陶灵刚 | Composite liposome for injection containing 12 vitamins and preparation method thereof |
CN101953830A (en) * | 2010-08-06 | 2011-01-26 | 南昌大学 | Method for preparing medium chain fatty acid-vitamin C compounded liposome by multi-emulsion-high-pressure microjet |
-
2014
- 2014-10-08 CN CN201410520174.0A patent/CN104256652A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101491499A (en) * | 2009-02-19 | 2009-07-29 | 陶灵刚 | Composite liposome for injection containing 12 vitamins and preparation method thereof |
CN101953830A (en) * | 2010-08-06 | 2011-01-26 | 南昌大学 | Method for preparing medium chain fatty acid-vitamin C compounded liposome by multi-emulsion-high-pressure microjet |
Non-Patent Citations (1)
Title |
---|
井乐刚,等: "复合维生素脂质体的制备", 《中国农学通报》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016197889A1 (en) * | 2015-06-12 | 2016-12-15 | 上海泽生科技开发股份有限公司 | Use of composition of vitamin complex in preparing drug for stimulating gastrointestinal system motility |
US10881639B2 (en) | 2015-06-12 | 2021-01-05 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Use of composition of multivitamin in preparing drug for stimulating gastrointestinal system motility |
US11351171B2 (en) | 2016-11-23 | 2022-06-07 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Composite vitamin composition promoting gastrointestinal system motility |
US11759463B2 (en) | 2016-11-23 | 2023-09-19 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Composite vitamin composition promoting gastrointestinal system motility |
CN106667793A (en) * | 2017-01-17 | 2017-05-17 | 上海应用技术大学 | D-panthenol microcapsules and preparation method thereof |
US11464797B2 (en) | 2017-03-07 | 2022-10-11 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Use of vitamin composition in preparing drug for preventing, treating, or delaying Alzheimer's disease |
CN107348514A (en) * | 2017-06-29 | 2017-11-17 | 安徽康博特保健食品有限公司 | A kind of preparation method of low-sugar type iron Couteat of Folic Acid |
CN113768057A (en) * | 2021-08-04 | 2021-12-10 | 深圳市红瑞生物科技股份有限公司 | Hair removing cream for cats |
CN114796119A (en) * | 2022-02-21 | 2022-07-29 | 重庆医科大学 | Composite antioxidant co-carried liposome and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104256652A (en) | Oral multi-vitamin nano liposome | |
Kaur et al. | Developments of Polysorbate (Tween) based microemulsions: Preclinical drug delivery, toxicity and antimicrobial applications | |
US11964019B2 (en) | Cochleates made with soy phosphatidylserine | |
CN101022786B (en) | Self emulsifying compositions for delivering lipophilic coenzyme Q10 and other dietary ingredients | |
Pangeni et al. | Oral delivery of quercetin in oil-in-water nanoemulsion: In vitro characterization and in vivo anti-obesity efficacy in mice | |
Demirci et al. | Encapsulation by nanoliposomes | |
CZ2003808A3 (en) | Process for preparing a formulation being present in the form of a liquid emulsion | |
CA2834968A1 (en) | Methods of making liposomes, liposome compositions made by the methods, and methods of using the same | |
ITMI20090264A1 (en) | COMPOSITION OF SPORE OF NON-PATHOGENIC BACTERIA | |
WO2017045034A1 (en) | Ubiquinone and ubiquinol compositions, and methods relating thereto | |
Kim et al. | The skin-permeation-enhancing effect of phosphatidylcholine: caffeine as a model active ingredient | |
CN103110578B (en) | Self-microemulsion composition of breviscapine phytosome and preparation method of composition | |
CN100536921C (en) | Supersaturated cationic self-emulsified drug delivery system and its preparation method | |
Zheng et al. | Improving intracellular uptake of 5-demethyltangeretin by food grade nanoemulsions | |
CN102686217A (en) | Submicro emulsion of paclitaxel using steroid complex as intermediate carrier | |
US11304900B1 (en) | Transparent colloidal vitamin supplement blend | |
Shishir et al. | Development and evaluation of a novel nanofibersolosome for enhancing the stability, in vitro bioaccessibility, and colonic delivery of cyanidin-3-O-glucoside | |
Li et al. | The preparation of Cistanche phenylethanoid glycosides liquid proliposomes: Optimized formulation, characterization and proliposome dripping pills in vitro and in vivo evaluation | |
CN101584661B (en) | Preparation of sorafenib self-microemulsifying drug delivery system for oral administration or intravenous injection and use thereof | |
CN106821789A (en) | A kind of preparation method of B B-complex nourishing cream and its liposomal thing | |
CN102258474B (en) | Preparation method of self-microemulsifying coenzyme Q10 powdery dry emulsion | |
CN108236604A (en) | Eliquis flexible lipidosome | |
Mandal et al. | Design and development of microemulsion drug delivery system of atorvastatin and study its intestinal permeability in rats | |
CN102247324A (en) | Flumazenil liposome injection | |
CN102247320B (en) | Etoposide long-circulating emulsion and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150107 |